関連する実験動画
Updated: Jul 17, 2026

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
ベータA4アミロイドタンパク質が,頭部外傷後の脳に蓄積される
G W Roberts1, S M Gentleman, A Lynch
1Department of Anatomy, St Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London, UK.
Lancet (London, England)
|December 7, 1991
まとめ
重度の頭部損傷は,脳内のベータA4アミロイドタンパク質の蓄積を急速に引き起こす可能性があります. この研究では,頭部外傷の数日以内に38%の患者で広範なベータA4アミロイドプラークが見つかりました.
科学分野:
- 神経科学は神経科学である.
- 神経病理学 神経病理学
- トラウマ性脳損傷による脳損傷
背景:
- 以前の研究では,頭部のトラウマが長期生存者のベータA4アミロイドプラークと関連している.
- アミロイドの蓄積に対する頭部損傷の急性効果は,あまり理解されていない.
研究 の 目的:
- 重度の頭部損傷が,ベータA4アミロイドタンパク質の急速な堆積を誘発する可能性を調査する.
- 頭部トラウマの短期生存者のアミロイドプラーク形成を調べる.
主な方法:
- 重度の頭部損傷で6~18日間生存した16人の患者 (10~63歳) を研究した.
- ベータA4アミロイドタンパク質に特異的な抗体による免疫ステーリングを活用した.
主要な成果:
- 16人の患者のうち6人の (38%) の脳皮質で,広範囲のβA4アミロイド堆積が観察されました.
- これらの発見は,重度の頭部損傷後のアミロイドの急速な堆積を示しています.
結論:
- 重度の頭部損傷は,数日以内に脳内のベータA4アミロイドの堆積を開始することができます.
- これは,急性脳外傷と早期の神経病理学的変化を結びつける潜在的なメカニズムを示唆しています.
関連する概念動画
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

